Suchergebnisse
Filter
8 Ergebnisse
Sortierung:
In iron light: Eeriness, decomposition and social movements
In: Culture and organization: the official journal of SCOS, Band 24, Heft 5, S. 408-425
ISSN: 1477-2760
When a career ends: a short story
In: Reflective practice, Band 10, Heft 4, S. 491-500
ISSN: 1470-1103
Careless Talk: Social Reproduction and Fault Lines of the Crisis in the United Kingdom
In: Social justice: a journal of crime, conflict and world order, Band 39, Heft 1, S. 78-98
ISSN: 1043-1578, 0094-7571
On a rainy evening in October 2011 the authors are sitting in the General Assembly of Occupy London Stock Exchange in the courtyard of St Paul's Cathedral. It is day four of the occupation, which is congregating here under the slogan "We are the 99 percent". This is in solidarity with occupations and protests across the globe. In this article, the authors argue that these movements, which have been interpreted as anti-austerity or anti-cuts movements, can be better understood as a response to a crisis of care. This crisis of care is precipitated by the economic crisis and the cuts being forced through by the government in the UK. This crisis of care is also one of political representation: increasing numbers of people are waking up to the fact that the state-capital nexus does not care about them in the sense that it does not promote, protect, or even consider their needs or interests. Adapted from the source document.
Careless Talk: Social Reproduction and Fault Lines of the Crisis in the United Kingdom
In: Social justice: a journal of crime, conflict and world order, Band 39, Heft 1, S. 78-98
ISSN: 1043-1578, 0094-7571
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy:Scotland's experience
In: Hutchinson , S J , Dillon , J F , Fox , R , McDonald , S A , Innes , H A , Weir , A , McLeod , A , Aspinall , E J , Palmateer , N E , Taylor , A , Munro , A , Valerio , H , Brown , G & Goldberg , D J 2015 , ' Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy : Scotland's experience ' International Journal of Drug Policy , vol 26 , no. 11 , pp. 1041-1049 . DOI:10.1016/j.drugpo.2015.05.019
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan - a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of accountable national and local multi-disciplinary multi-agency networks responsible for the planning, development and delivery of services. Initiatives ranged from the introduction of testing in specialist drug services through finger-prick blood sampling by non-clinical staff, to the setting of government targets to ensure rapid scale-up of antiviral therapy. The Plan was informed by comprehensive national monitoring systems, indicating the extent of the problem not just in terms of numbers infected, diagnosed and treated but also the more penetrative data on the number advancing to end-stage liver disease and death, and also through compelling modelling work demonstrating the potential beneficial impact of scaling-up therapy and the mounting cost of not acting. Achievements include around 50% increase in the proportion of the infected population diagnosed (38% to 55%); a sustained near two-and-a-half fold increase in the annual number of people initiated onto therapy (470 to 1050) with more pronounced increases among PWID (300 to 840) and prisoners (20 to 140); and reversing of an upward trend in the overall number of people living with chronic infection. The Action Plan has demonstrated that a Government-backed, coordinated and invested approach can transform services and rapidly improve the lives of thousands. Cited as "an impressive example of a national strategy" by the Global Commission on Drug Policy, the Scottish Plan has also provided fundamental insights of international relevance into the management of HCV among PWID.
BASE
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy:Scotland's experience
In: Hutchinson , S J , Dillon , J F , Fox , R , McDonald , S A , Innes , H , Weir , A , McLeod , A , Aspinall , E J , Palmateer , N E , Taylor , A , Munro , A , Valerio , H , Brown , G & Goldberg , D 2015 , ' Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy : Scotland's experience ' , International Journal of Drug Policy , vol. 26 , no. 11 , pp. 1041-1049 . https://doi.org/10.1016/j.drugpo.2015.05.019
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan – a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of accountable national and local multi-disciplinary multiagency networks responsible for the planning, development and delivery of services. Initiatives ranged from the introduction of testing in specialist drug services through finger-prick blood sampling by nonclinical staff, to the setting of government targets to ensure rapid scale-up of antiviral therapy. The Plan was informed by comprehensive national monitoring systems, indicating the extent of the problem not just in terms of numbers infected, diagnosed and treated but also the more penetrative data on the number advancing to end-stage liver disease and death, and also through compelling modelling work demonstrating the potential beneficial impact of scaling-up therapy and the mounting cost of not acting. Achievements include around 50% increase in the proportion of the infected population diagnosed (38% to 55%); a sustained near two-and-a-half fold increase in the annual number of people initiated onto therapy (470 to 1050) with more pronounced increases among PWID (300 to 840) and prisoners (20 to 140); and reversing of an upward trend in the overall number of people living with chronic infection. The Action Plan has demonstrated that a Government-backed, coordinated and invested approach can transform services and rapidly improve the lives of thousands. Cited as ''an impressive example of a national strategy'' by the Global Commission on Drug Policy, the Scottish Plan has also provided fundamental insights of international relevance into the management of HCV among PWID.
BASE
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan – a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of accountable national and local multi-disciplinary multi-agency networks responsible for the planning, development and delivery of services. Initiatives ranged from the introduction of testing in specialist drug services through finger-prick blood sampling by non-clinical staff, to the setting of government targets to ensure rapid scale-up of antiviral therapy. The Plan was informed by comprehensive national monitoring systems, indicating the extent of the problem not just in terms of numbers infected, diagnosed and treated but also the more penetrative data on the number advancing to end-stage liver disease and death, and also through compelling modelling work demonstrating the potential beneficial impact of scaling-up therapy and the mounting cost of not acting. Achievements include around 50% increase in the proportion of the infected population diagnosed (38% to 55%); a sustained near two-and-a-half fold increase in the annual number of people initiated onto therapy (470 to 1050) with more pronounced increases among PWID (300 to 840) and prisoners (20 to 140); and reversing of an upward trend in the overall number of people living with chronic infection. The Action Plan has demonstrated that a Government-backed, coordinated and invested approach can transform services and rapidly improve the lives of thousands. Cited as "an impressive example of a national strategy" by the Global Commission on Drug Policy, the Scottish Plan has also provided fundamental insights of international relevance into the management of HCV among PWID.
BASE